Johannes CB, Le TK, Zhou X, Johnston JA, Dworkin RH. The prevalence of chronic pain in United States adults: results of an internet-based survey. J Pain. 2010 Nov 1;11(11):1230-9.
Johannes CB, Chiang CC, Ng EW, Eng PM, Seeger JD, Walker AM. Treatment patterns in patients using biological disease modifying antirheumatic therapy for rheumatoid arthritis. Presented at the 21st International Conference on Pharmacoepidemiology; August 2005. Nashville, TN. [abstract] Pharmacoepidemiol Drug Saf. 2005 Sep; 14(Suppl 2):S195. doi: 10.1002/pds.1136
Eng PM, Johannes CB, Chaing CC, West WA, Seeger JD. Survey of disability, medication use, and medication satisfaction among members with rheumatoid arthritis of a large health care plan database. Poster presented at the 21st International Conference on Pharmacoepidemiology; August 2005. Nashville, TN. [abstract] Pharmacoepidemiol Drug Saf. 2005 Aug; 14(Suppl 2):S5.
Johannes CB, Schneider GA, Walker AM, Viveash D, Wallis WJ. Increased incidence of lymphoma among patients with rheumatic diseases based on automated insurance claims information. Presented at the 20th ICPE International Conference on Pharmacoepidemiology & Therapeutic Risk Management; August 22, 2004. Bordeaux, France. [abstract] Pharmacoepidemiol Drug Saf. 2004 Sep 23; 13:S239.
Johannes CB, Schneider GA, Walker AM, Zhao S, Shibata A. Validation of a propensity score developed using claims data in controlling for health status of rheumatic disease patients initiating etanercept compared with other DMARDS. Presented at the 20th ICPE International Conference on Pharmacoepidemiology & Therapeutic Risk Management; August 22, 2004. Bordeaux, France. [abstract] Pharmacoepidemiol Drug Saf. 2004 Sep 23; 13(S1):S16.
Johannes CB, Zhao S, Shibata A, Schneider G, Wallis W, Walker A. Propensity score analysis in balancing underlying disease severity among rheumatic disease patients treated with etanercept or another DMARD. Poster presented at the American College of Rheumatology Annual Scientific Meeting; 2004.
Johannes CB, Schneider G, Aygun AC, L'Italien GJ, Viveash D, Wallis WJ. Time to first disease modifying anti-rheumatic drug therapy (DMARD) among rheumatic disease patients in a population based study. Poster presented at the American College of Rheumatology Annual Scientific Meeting; 2003.